Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Baclofen

A muscle relaxant that stimulates GABA-B receptors in the nervous system, synthesised in Switzerland in 1962 by chemist Heinrich Keberle: it is used to reduce spasticity, for example in multiple sclerosis and spinal cord injury. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.

Did you know?It was designed as a treatment for epilepsy: results there were disappointing, but it was noticed that spasticity decreased in some patients.

BaclofenGo to the active ingredient →
BaclofenActive ingredientBaclofenCat. No. P-B002-001CAS 1134-47-0
Baclofen-d4Isotopically labelledBaclofen-d4Cat. No. P-B002-013CAS 1189938-30-4

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Reference substanceBaclofen CRSEDQM code B0200000Family Baclofen

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.